We used Western blot and immunohistochemical methods to investigate the biochemical characteristics and cellular distribution of a novel peptide (peptide 23) that was previously shown to be released from anterior pituitary cells of rat in response to growth hormone-releasing hormone. In the pituitary, peptide 23 isolated from intact cells had an Mr of 31,000, whereas that released into culture medium had an Mr of 16,000. Pancreatic islets contained a 19 M) form of the peptide. Immunohistochemically, peptide 23 in the rat pituitary gland was localized in a subpopulation of somatotropes. In pancreatic islets, the peptide was found by triple immunofluorescence labeling to be present in both insulinand somatostatin-containing cells. In the gastrointestinal
Introduction
We have previously reported that the secretion of three novel proteins from cultured rat pituitary cells is increased by growth hormone-releasing hormone (GHRH) and decreased by somatostatin (Yokoya and Friesen, 1986) . These proteins had an approximate molecular mass of 16 KD and have been designated peptides 23, 24, and 25. The N-terminal amino acid sequence of peptide 23 has been established by microsequencing. Antibodies generated in rabbits against a synthetic peptide corresponding to amino acid residues 3-24 ofpeptide 23 crossreacted with peptides 23,24, and 25, indicating some degree of homology or the presence of common epitopes among these substances (Echibana et al., 1988) . These antibodies did not recognize rat growth hormone (rGH) and, conversely, antibodies directed against rGH did not recognize any of these three peptides (Yokoya and Friesen, 1986) . Moreover, initial sequence comparisons revealed no significant homologies with rGH or with any other known protein (Echibana et al., 1988) . However, a recent search indicated that the amino acid sequence 1-24 of peptide 23 has 50% homology with what has been termed regenerating (reg) protein. The mRNA of reg-protein was found tract, peptide 23 was found only in a subpopulation of endoctine cells in the pyloric glands. This subpopulation of cells was found to be entirely separate from those containing either serotonin or somatostatin, and may represent one of the other known or as yet biochemically uncharacterized cell types in this gland. The results suggest that in response to secretagogues in vitro, an altered form of the peptide is secreted from pituitary cells and that an intracellular form of peptide 23 is expressed in some but not all somatotropes, a large proportion of islet cells, and a distinct population of pyloric cells. to be expressed in regenerating and hyperplastic pancreatic islets but not in normal islets (Terazono et al., 1988) . More recently, it was reported that most if not all of reg mRNA was localized to exocrine tissue of the pancreas (Miyaura et al., 1991) . The suggestion was made that reg protein might function as a paracrine factor mediating the symbiotic relationship between the exocrine and endocrine pancreas.
Although very little is known about the expression, disposition, and function of peptide 23, the above findings point to the possibility that it may be closely associated with the endocrine system and that it may participate in regulatory actions exerted by this system. To pursue this notion, we used Western blot and immunohistochemical methods to investigate the distribution of peptide 23 in the pituitary, gastrointestinal tract, and pancreas. We report that peptide 23-like immunoreactivity is restricted to a subpopulation of somatotropes in the pituitary, somatostatin-and insulincontaining cells in the pancreatic islets, and a subpopulation of endocrine cells in the pyloric glands.
Materials and Methods
Antibody. A synthetic peptide corresponding to amino acids 3-24 of peptide 23 was conjugated to keyhole limpet hemocyanin (KLH) and injected into rabbits. The specificity characteristics of this antibody and its lack of crossreaction with either rGH or prolactin have been previously described (Tachibana et al.. 1988). The preparation and specificity characteristics of the other primary antibodies used are given in the references listed in Table 1 (Yokoya and Friesen, 1986) a Among the five immunofluorescence processing procedures listed. those conductc 3; 1 with 4; and 1 with 5 .
Westem Blots. Extracts of anterior pituitary were prepared from 25 normal male Sprague-Dawley rats weighing 250-300 g. The pituitaries were homogenized in 2 ml ice-cold 0.05 M Tris-HCI buffer, p H 9.2. The homogenate was continuously stirred at 4'C for 2 hr and then centrifuged at 5000 x g for 30 min. The supernatant was adjusted to pH 8.0 and stored at -20°C. After thawing, the pituitary extract was centrifuged as before, applied to approximately 90 ml of Sephadex G-100 superfine, and eluted with 0.05 M ammonium bicarbonate buffer, p H 8.0. Fractions of 1.5 ml were taken for Western blots. For analysis of peptide release, dispersed rat anterior pituitary cells were prepared as described previously (Yokoya and Friesen, 1986) and suspended in Dulbecco's modified Eagle's medium (DMEM; Grand Island Biological, Grand Island. NY) supplemented with 30% fetal calf serum, 100 U/ml penicillin, 100 pg/ml streptomycin. and 2 mM glutamine. The cells were plated in 35-mm dishes (1.0-1.5 x lo6 cells/ml) and incubated at 37'C in humidified air with 5 % CO2 for 3 days. The cells were washed three times with DMEM and then incubated in DMEM supplemented with penicillin, streptomycin, and glutamine for another 8 hr. At the end of the incubation period, media were centrifuged at 1000 rpm for 5 min and the supernatant received a change of buffer to 0.01 M ammonium bicarbonate (pH 8.0) with use of a Centricon 10 microconcentrator (Amicon). The samples were then dried in a Speed-Vac concentrator. The dried samples were dissolved in 20 p1 of Laemmli's sample buffer (Laemmli, 1970) . boiled for 5 min. and together with the above pituitary extracts were analyzed by sodium dodecyl sulfate-polyacrylamide gel (15%) electrophoresis (SDS-PAGE). After SDS-PAGE. separated proteins were transferred to nitrocellulose paper and probed with anti-peptide 23[3-241 antiserum (1:lOOO) and goat anti-rabbit IgG conjugated to alkaline phosphatase as described previously (Echibana et al., 1988; Yokoya and Friesen, 1986) . Approximately 700 pancreatic islets from adult Sprague-Dawley rats were homogenized in 50 p1 of Laemmli's sample buffer. Aliquots (20 pl) of islet extracts were taken for Western blot analysis as described above.
Immunohistochemistry. Male Sprague-Dawley rats (250-350 g) were deeply anesthetized with chloral hydrate and perfused transcardially with 70 ml of cold 50 mM sodium phosphate buffer (PB), pH 7.5, containing 0.9% saline. 0.1% sodium nitrite, and heparin (1 U/ml), followed by 200 ml of cold 4% paraformaldehyde in 0.1 M PB (pH 7.5), then 200 ml of cold 4% paraformaldehyde in 50 mM borate buffer (pH 9.0). The pituitary, pancreas, adrenal gland, thyroid and parathyroid glands, pineal gland, stomach, duodenum, jejunum, ileum. and colon were removed, post-fixed in borate-buffered fixative for 16 hr. and then cryoprotected in 50 mM PB containing 15% sucrose. Cryostat sections cut at a thickness of 10 pm were thaw-mounted onto glass slides, washed in PB containing 0.9% saline (PBS) for 16 hr, and then incubated for 48 hr at 4'C with rabbit anti-peptide 23 antibody diluted 1:lOOO in PBS containing 0 . 3 1 Triton-X and 1% bovine serum albumin (PBST-BSA). The antibody was pre-absorbed for 2 hr at room temperature with KLH (0.25 mg/ml) before this incubation. For the peroxidase-anti-peroxidase (PAP) method, sections were rinsed for 1 hr in PBS containing 0.3% Triton-X (PBST), incubated for 1.5 hr at room temperature with anti-rabbit IgG (Sternberger-Meyer) diluted 1:20 in PBST-BSA. washed for 1 hr in PBST and incubated for 1.5 hr at room tempcrature with rabbit PAP (Sternberger-Meyer; Jarrettsvillc, MD) diluted 1:lOO in PBST-BSA. After a 30-min wash in 0.05 M Tris-HC1 buffer (pH 7.4), the sections were reacted for 5-10 min in the same buffer containing 0.02% 3.3'-diaminobenzidine hydrochloride (DAB) and 0.005% hydrogen peroxide. For immunofluorescence methods involving double and triple labcling in the same section. tissues were incubated for 48 hr at 4°C in a mixture offm antibodies diluted in PBST-BSA, washed for 1 hr. and then incubated in a mixture of secondary antibodies for 1 hr as shown in Table 1 . In some cases, the sections were washed for 1 hr and incubated with a third antibody for 1 hr (Table 1) . Control experiments were performed with prcimmune serum (1:1000), with omission of anti-peptide 23 scrum in the first incubation step. and with antibody pre-absorbed with KLH-conjugated peptide 23 (100 pglml). For double and triple staining involving each of the primary antibody combinations emplopd. control procedures were carried out by incubating sections with only a single firsr antibody followed by incubation with secondary antibodies directed against the omitted first antibodies. We have previously described in detail the protocols for such controls in studies involving triple immunofluorescence labeling (Staines et al., 1988) . Sections were examined with a Dialux 20 microscope (Leitz) equipped with an I2 and an N2 cube. and a modified B2 Ploemopak filter cube for demonstration of fluorescein isothiocyanate (FITC), T m s Red. and diethylaminocoumarin (DMAC) fluorescence. respectively (see Sraincs et al.. 1986a Sraincs et al.. .1988 for details).
Immunoelectron Microscopy. For electron microscopy, tissues that had been cryoprotected in 25% sucrose containing 50 mM PB and 10% glycerol were frozen and cut at a thickness of 30 pm on a sliding microtome. Sections were collected and washed in PBS for 16 hr and then processed by the PAP method as above. except without detergent in the wash or antibody incubation steps. The sections were then fixed for 2 hr at room tcmperature in 2% osmium tetroxide diluted in 0.1 M PB (pH 7.4). dehydrated. flat-embedded in Jembed, and desired areas selected by light microscopic inspection were glued onto resin blocks. Ultra-thin sections were collected on mesh grids and counterstained with lead citrate for 2 min. creatic islets, the anti-peptide 23 antibody recognized only a single species of 19 KD (data not shown).
Results

Western Bl'ot Anal'ysis
Light Microscopic Observations
Among the tissues tested, peptide 23-like immunoreactivity was observed only in the pituitary, pancreatic islets, and the pyloric glands. This immunoreactivity was abolished by pre-absorption of anti-peptide 23 antibody with KLH-conjugated peptide ( Figures  4A and 4E) . No detectable differences in staining profiles were seen between antiserum and the serum pre-absorbed with KLH. No immunostaining was seen in these three tissues with omission of peptide 23 antiserum or when pre-immune serum was substituted for peptide 2 3 antiserum in the immunohistochemical procedures. Similar results were obtained by PAP and immunofluorescent methods, except that endogenous peroxidase-containing cells, presumably eosinophilic leukocytes, were labeled in the lamina propria and the submucosa of the alimentary tract by the PAP technique even after omission of first antibody. From control experiments involving double and triple staining, no fluorescent cells were seen after incubation with a single first antibody followed by application of inappropriate secondary or tertiary antibodies.
In the pituitary, peptide 23-like immunoreactive (P23-IR) cells were evenly scattered throughout the anterior lobe; no tendency for clustering was evident (Figure 2A) . Labeled cells were polygonal, triangular, or ovoid and ranged between 10-20 pm in diameter ( Figure 2C ). Comparative analysis with the localization of rGHimmunoreactive cells showed that all P23-IR cells also contained rGH. However, only about 15 % of all rGH-labeled cells displayed P23 immunofluorescence (Figures 2A and 2B) . Unlike P23-IRcells, those labeled for only rGH were comparatively uniform in shape (round or ovoid) and exhibited less variation in size (10-15 pm) ( Figures 2C and 2D) . No P23-IR cells were detected in the intermediate and posterior lobes.
In pancreatic islets, P23-IR cells were more numerous than unlabeled cells ( Figure 3B ). Immunopositive cells had a granular appearance and varied from 9-18 pm in diameter. By triple labeling within a single section ( Figures 3A-3C ), these P23-IR cells contained insulin or somatostatin. All insulin-positive and all somatostatin-positive (pancreatic D-cells) appeared to be labeled with antiserum against peptide 23. Somatostatin-containing cells usually exhibited greater immunolabeling intensity for peptide 23 in comparison with insulin-containing cells. Frequently, cells that were unlabeled for peptide 23, somatostatin, and insulin were observed in the periphery of the pancreatic islets. These cells tended to be smaller (about 9 pm in diameter) than P23-IR cells, and are presumably glucagon-containing cells. The filamentous immunofluorescent staining seen outside of pancreatic islets in Figure 3B was sometimes present after omiiion of primary antibody and was not eliminated after pre-absorption of the anti-peptide 23 antibody with peptide 23. Therefore, this staining was considered to be nonspecific. In the alimentary tract, P23-IR cells were found only in the pyloric gland ( Figures 4A-4D) ; no detectable immunolabeling was seen in the rest of the gastrointestinal tract. The pyloric P23-IR cells had a granular appearance, were scattered in the gastric epithelium, and all appeared to be associated with gastric pits. The majority were located at the base of the pits; a small number were seen mid-way along these, and none were seen in the apical region. P23-IR cells located deep in the pits were either triangular, round (about 10 pm in diameter), or ovoid (6 pm x 20 pn), and tended to occur in clusters ( Figures SA) . Frequently, these cells extended conoid apical and basal processes. The latter usually exhibited greater immunofluorescence intensity than the former. The P23-IR cells located at the mid-level of the pits were ovoid or spindle-shaped and extended straight, slender apical processes which exhibited weak immunoreactivity and appeared to reach the lumen of the gastric pit, and slightly thicker basal processes which were more intensely immunoreactive than the apical processes. Double immunolabeling studies indicated that these pyloric P23-IR cells did not contain either somatostatin or serotonin ( Figures SA-SD) .
Electron Microscopy
Ultrastructural analysis was conducted only on the pyloric glands. Correlative LM-EM analysis showed that cells in these structures immunolabeled by the PAP method as seen by LM were also clearly labeled by EM. These cells had relatively large invaginated nuclei with prominent nucleoli ( Figure 6A) . A characteristic feature was the presence of 150-200-nm secretory granules which had a vacuolar appearance ( Figure 6B ), and these granules frequently contained small (about 20 nm) and moderately electron-dense fragments (Fig-Figure 5. (A,B) ure 6D). Spindle-shaped or ovoid P23-IR cells contained fewer such secretory granules than round or flask-shaped cells. Vacuoles in the apical region of labeled cells were often smaller (70-100 nm) than those more centrally located ( Figure 6C ). Several electron-dense granules (210-250 nm) were also found within these cells ( Figure  6C ). Immunolabeling was observed mainly on free ribosomes (20-25 nm) that were concentrated within regions between secretory granules and in association with granular endoplasmic reticulum ( Figures  6B-6E) . No immunoreaction was observed in EC cells characterized by the presence of electron-dense, morphologically heterogeneous secretory granules, or in cells intercalated between these cells and labeled cells.
Discussion
The present immunohistochemical results indicate that peptide 23 is expressed by subpopulations of somatotropes and gastroenteropancreatic (GEP) endocrine cells. The results on peptide 23 secretion in vitro suggest that the intracellular form of peptide 23 in both pituitary and pancreas is larger than that secreted from the pituitary. It appears that peptide 23 has different intracellular and extracellular forms and that the intracellular form may be organspecific.
In extracts of rat pituitary, a 31 KD protein was the only component found to crossreact with antibodies against peptide 23. Although we cannot eliminate the possibility that a small amount of the 16 KD peptide 23 exists intracellularly, the 31 KD peptide appears to be more abundant within pituitary cells and may represent a precursor of the 16 KD form. Assuming such a precursor-product relationship, the results imply rapid intracellular turnover. rapid release, or low steady-state quantities of the lower molecular weight form. Our immunohistochemical results show that the intracellular form of peptide 23 is present only in a small portion of somatotropes in the rat pituitary. The biochemical heterogeneity of rat somatotropes indicated by their peptide 23 content provides support for earlier observations suggesting the presence of at least two morphologically and functionally distinct subpopulations of somatotropes in the rat (Frawley et al., 1985; Snyder et al., 1977) . Thus, GH-containing cells were separated into two subpopulations of somatotropes and mammosomatotropes (Nikitovitch-Winer et al., 1987; Frawley et al.. 1985) . A minor population containing sparse secretory granules and designated Type I1 cells represented 15% of somatotropes (Snyder et al., 1977) . Based on the frequency of occurrence of peptide 23-containing cells, they may correspond to the sparsely granulated somatotropes.
In pancreatic islets, it appears that all insulin-containing cells express peptide 23 under normal physiological conditions. In addition, somatostatin-containing D-cells, which are known to be devoid of insulin, were also found to contain peptide 23. However, gastroenteric somatostatin-containing cells were devoid of P23 immunoreactivity. Therefore, as in the case of its expression by a subpopulation of somatotropes in the pituitary, peptide 23 is expressed by a subpopulation of somatostatin-containing cells in the GEP endocrine system, suggesting the lack of a strict relationship between P23-IR cells and somatostatin. With regard to the recently described reg-protein in the pancreas, the significance of the 50% sequence homology of peptide 23 with this protein is uncertain. In any case, our immunolabeling studies of pancreatic islets were conducted with normal animals, whereas reg-protein appears to be present only in regenerating islets. Moreover, although the molecular weight of reg-protein corresponds to that of peptide 23, there appears to be some uncertainty in the localization of this protein. In contrast to an earlier report (Terazono et al., 1988) , reg "A and protein have now been detected in normal pancreatic exocrine cells by in situ hybridization and immunohistochemistry, and the reg-protein is still found only in regenerating pancreatic islets by immunohistochemistry (Miyaura et al., 1991; Terazono et al., 1990; Newgard et al., 1989) . Therefore, it is unlikely that P23-IR in pancreatic islets represents a crossreaction with reg-protein, although we cannot entirely exclude this possibility.
In the stomach, the pyloric glands contain several types of endocrine cells, which to some extent have been distinguished from each other by various criteria (Solcia et al., 1987; Kataoka et al., 1979; Fujita and Kobayashi. 1977; Solcia et al., 1975) . Notwithstanding species differences, the cell types and their constituent distinguishing substance include G (gastrin), ECL (histamine), X (unknown), PP (pancreatic peptide), D (somatostatin), EC (serotonin), and P/D1 (unknown) cells (Solcia et al., 1987) . Although the present results exclude the presence of peptide 23 in EC and D-cells, it remains uncertain which of the remaining cell types express this peptide. The ultrastructural morphology of secretory granules in P23-IR cells corresponded to those in histamine-containing enterochromafh-like (ECL) cells in that they exhibited a collapsed dense core separated by a space from the granule limiting membrane. However, ECL cells, unlike P23-IR cells, are present in both the pyloric and fundic glands (Panula et al., 1985 (Panula et al., ,1988 Watanabe et al., 1983) , and are classified as the closed type of pyloric endocrine cell (Kubota et al., 1984; Capella et al., 1971 ). On the other hand, the distribution of peptide 23-containing cells in the stomach corresponded by several criteria to that of the gastrin-containing cells (G-cells). Therefore, like G-cells, P23-IR cells are present only in the pyloric glands, are classified as open-type endocrine cells in that their apical processes reach the lumina of the gastric pits, and contain uniformly filled secretory granules that exhibit moderate electron density in tissue fixed by glutaraldehyde (Solcia et al., 1975 (Solcia et al., ,1987 Vassallo et al., 1969) . Assuming such a correspondence, the weaker paraformaldehyde fixation used here may have caused the collapsed central cores of secretory granules in P23-IR cells. By EM, immunolabeling for peptide 23 within these cells was seen to be associated mainly with free ribosomes. However, immunogold methods will be required to determine the exact intracellular localization of this peptide and to establish whether or not it is present in secretory granules.
Hormonal influences of effector organs have been classified as involving endocrine, paracrine, and autocrine mechanisms. The coordinated actions of bioactive substances and/or related proteins with classical hormones in these mechanisms is a well-known phenomenon (Simon et al., 1988; Grube, 1986; Rundle et al., 1986; Winkler et al., 1986; Owman et al., 1973; Pearse et al., 1969) . The highly restricted distribution of peptide 23 in cells of the GEP endocrine system suggests that it may participate in such hormonal regulatory interactions. However, further characterization of peptide 23 and examination of its biological effects are required to determine whether it is a novel pituitary/gastrointestinal hormone andlor a regulatory substance.
